{"id":"tp-44670","type":"article-newspaper","title":"FDA Approves NRx Pharmaceuticals’ Generic Ketamine Injection","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/44670","datePublished":"2026-10-30T12:38:19.000Z","dateModified":"2026-10-30T12:38:19.000Z","language":"en","abstract":"NRx shares rose more than 15% in premarket trading Friday, Oct. 30. The approval may help ease U.S. supply constraints for ketamine used in pain treatment and anesthesia.","section":"Regulation","references":[]}